Lista de obras - Miriam Marqués - Dominio Público Uruguay

A PI3K activity-independent function of p85 regulatory subunit in control of mammalian cytokinesis

artículo científico publicado en 2006

A cascade involving p85, Cdc42 and septin 2 regulates cytokinesis

artículo científico publicado en 2007

Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors.

artículo científico publicado en 2016

Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead

scientific journal article

Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing

artículo científico publicado en 2004

E-cadherin downregulation sensitizes PTEN-mutant tumors to PI3Kβ silencing.

artículo científico publicado en 2016

Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors

artículo científico publicado en 2010

PIK3CA gene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors

artículo científico publicado en 2013

PIcKing on Fibroblast Growth Factor Receptors as Bladder Cancer Therapeutic Targets

artículo científico publicado en 2017

Phosphoinositide 3-kinase activation in late G1 is required for c-Myc stabilization and S phase entry

artículo científico publicado en 2006

Phosphoinositide 3-kinase controls early and late events in mammalian cell division

artículo científico publicado en 2006

Phosphoinositide 3-kinase gamma participates in T cell receptor-induced T cell activation.

artículo científico publicado en 2007

Phosphoinositide 3-kinases p110alpha and p110beta regulate cell cycle entry, exhibiting distinct activation kinetics in G1 phase

artículo científico publicado en 2008

Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models

artículo científico publicado en 2021

Specific function of phosphoinositide 3-kinase beta in the control of DNA replication

scholarly article

Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome

artículo científico publicado en 2013

The N-Terminal Phosphorylation of RB by p38 Bypasses Its Inactivation by CDKs and Prevents Proliferation in Cancer Cells.

artículo científico publicado en 2016

p85β phosphoinositide 3-kinase subunit regulates tumor progression

artículo científico publicado en 2012

Lista de obras de Miriam Marqués

A PI3K activity-independent function of p85 regulatory subunit in control of mammalian cytokinesis

A cascade involving p85, Cdc42 and septin 2 regulates cytokinesis

Choline Kinase Alpha (CHKα) as a Therapeutic Target in Pancreatic Ductal Adenocarcinoma: Expression, Predictive Value, and Sensitivity to Inhibitors.

Control of cyclin G2 mRNA expression by forkhead transcription factors: novel mechanism for cell cycle control by phosphoinositide 3-kinase and forkhead

Differential requirements for DOCK2 and phosphoinositide-3-kinase gamma during T and B lymphocyte homing

E-cadherin downregulation sensitizes PTEN-mutant tumors to PI3Kβ silencing.

Multiple oncogenic mutations and clonal relationship in spatially distinct benign human epidermal tumors

PIK3CA gene alterations in bladder cancer are frequent and associate with reduced recurrence in non-muscle invasive tumors

PIcKing on Fibroblast Growth Factor Receptors as Bladder Cancer Therapeutic Targets

Phosphoinositide 3-kinase activation in late G1 is required for c-Myc stabilization and S phase entry

Phosphoinositide 3-kinase controls early and late events in mammalian cell division

Phosphoinositide 3-kinase gamma participates in T cell receptor-induced T cell activation.

Phosphoinositide 3-kinases p110alpha and p110beta regulate cell cycle entry, exhibiting distinct activation kinetics in G1 phase

Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models

Specific function of phosphoinositide 3-kinase beta in the control of DNA replication

Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome

The N-Terminal Phosphorylation of RB by p38 Bypasses Its Inactivation by CDKs and Prevents Proliferation in Cancer Cells.

p85β phosphoinositide 3-kinase subunit regulates tumor progression